Normative Reference Values of Equilibrium Coordination Test Among Children

October 4, 2023 updated by: Asir John Samuel

Normative Reference Values of Sideways Walking, Tandem Walking, Cross-stepping, Heel Walking and Toe Walking Among Children

A cross-sectional study will be conducted recruiting children of age group 8-15 years. Pilot study has been conducted for the determination of the sample size. The calculated sample size has come out to be, n=378 which can be taken for males and females separately. Stratified random sampling will be done according to age. Child will be asked to perform all tests one by one and the time taken (in seconds) will be noted required to perform the tests. The mean of three readings will be obtained using a mobile-based stop watch.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

756 children will be recruited of age group 8-15 years. Five equilibrium coordination tests i.e. Sideways walking, tandem walking, cross-stepping, heel walking and toe walking will be performed by each child and three readings will be recorded. Mean of three readings will be considered as normative reference value of each test respectively.

Study Type

Observational

Enrollment (Actual)

1104

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haryana
      • Ambāla, Haryana, India, 133207
        • Maharishi Markandeshwar International School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 15 years (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Normal healthy children of age group between 8 and 17 years was recruited

Description

Inclusion Criteria:

  • Typically developing school-going children with age group between 8 and 15 years
  • Both male and female
  • Able to walk independently
  • Able to follow verbal commands

Exclusion Criteria:

  • Any fracture of lower limb in last 6 months
  • Any congenital anomaly affecting lower limb
  • Any developmental disorder
  • Any open wounds
  • Those who are using any kind of assistive devices
  • Any condition that affect the health status of the participants during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sideways walking
Time Frame: Immediately after the sideways walking
This test will be used to find the normative values of sideways walking
Immediately after the sideways walking
Tandem walking
Time Frame: Immediately after the Tandem walking
This test will be used to find the normative values of tandem walking
Immediately after the Tandem walking
Cross stepping
Time Frame: Immediately after the Cross stepping
This test will be used to find the normative values of cross stepping
Immediately after the Cross stepping
Heel Walking
Time Frame: Immediately after the Heel Walking
This test will be used to find the normative values of heel walking
Immediately after the Heel Walking
Toe walking
Time Frame: Immediately after the Toe walking
This test will be used to find the normative values of toe walking
Immediately after the Toe walking

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nidhi Sharma, PhD Scholar, Maharishi Markendeshwar University (Deemed to be University)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 2, 2021

Primary Completion (Actual)

August 19, 2023

Study Completion (Actual)

September 16, 2023

Study Registration Dates

First Submitted

October 1, 2021

First Submitted That Met QC Criteria

December 2, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

October 5, 2023

Last Update Submitted That Met QC Criteria

October 4, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MMDU/IEC/2153
  • U1111-1269-9876 (Other Identifier: Universal Trial Number (WHO))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coordination Disorder, Developmental

Clinical Trials on Reference values

Subscribe